FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma
by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T
Updated on: March 30,2024
0

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma
by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T
Updated on:March 30,2024
0
